Celgene Corp to buy VC-backed Quanticel for up to $485 mln

Celgene Corporation has agreed to acquire San Francisco-based Quanticel Pharmaceuticals Inc, a provider of genomic analysis of human cancer, for up to $485 million. Quanticel is backed by Versant Ventures.

DealsNorth AmericaUSBriefs